{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:33:03Z","timestamp":1777480383020,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:p>BACKGROUND: Breast cancer (BC) is a common malignancy in women. Some molecules, including endocan, are still under investigation as potential prognostic factors in BC. OBJECTIVE: In the present study, we aimed to determine the relationship between endocan expression and clinicopathological prognostic parameters in BC. METHODS: Two hundred and fifty-five patients diagnosed with BC were included in the present study. The immuno-reactivity scoring (IRS) system was used to reveal the tissue endocan expression levels. RESULTS: We found that endocan expression is associated with tumor necrosis, tumor size, and the presence of lobular carcinoma in situ (LCIS) in BC. There was no relationship between endocan expression and survival as well as other clinicopathological prognostic parameters. CONCLUSION: Endocan overexpression in BC is associated with some prognostic parameters, including tumor necrosis, tumor size, and the presence of LCIS. Further studies with larger series are needed to reveal the clinical and therapeutic implications of endocan in BC.<\/jats:p>","DOI":"10.3233\/cbm-201026","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T14:42:37Z","timestamp":1624027357000},"page":"471-477","source":"Crossref","is-referenced-by-count":1,"title":["Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma"],"prefix":"10.1177","volume":"32","author":[{"given":"Zeliha Esin","family":"Celik","sequence":"first","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Selcuk University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Demir","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Selcuk University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harun","family":"Yonar","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Faculty of Veterinary Medicine, Selcuk University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Ugras","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Selcuk University, Konya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-201026_ref1","first-page":"15","article-title":"Serum endocan level and its prognostic significance in breast cancer patients","volume":"4","author":"Ates","year":"2018","journal-title":"JOS"},{"issue":"4","key":"10.3233\/CBM-201026_ref2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000346475","article-title":"Correlation between Ki67 and breast cancer prognosis","volume":"84","author":"Kontzoglou","year":"2013","journal-title":"Oncology"},{"issue":"3","key":"10.3233\/CBM-201026_ref3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/0973-1482.137927","article-title":"Breast cancer statistics and markers","volume":"10","author":"Donepudi","year":"2014","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"10.3233\/CBM-201026_ref4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/bcr777","article-title":"Prognostic molecular markers in early breast cancer","volume":"6","author":"Esteva","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.3233\/CBM-201026_ref5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ebiom.2019.07.046","article-title":"A 23 gene-based molecular prognostic score precisely predicts overall survival of breast cancer patients","volume":"46","author":"Shimizu","year":"2019","journal-title":"EBio Medicine"},{"key":"10.3233\/CBM-201026_ref6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4172\/1948-5956.1000022","article-title":"Endocan as a biomarker of endothelial dysfunction in cancer","volume":"2","author":"Sarrazin","year":"2010","journal-title":"J Cancer Sci Ther"},{"issue":"28","key":"10.3233\/CBM-201026_ref7","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.3748\/wjg.14.4562","article-title":"Correlation between expression and differentiation of endocan in colorectal cancer","volume":"14","author":"Zuo","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.3233\/CBM-201026_ref8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10620-008-0346-3","article-title":"Endocan expression correlated with poor survival in human hepatocellular carcinoma","volume":"54","author":"Huang","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.3233\/CBM-201026_ref9","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00404-013-2863-3","article-title":"Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer","volume":"288","author":"Seksaka","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"41","key":"10.3233\/CBM-201026_ref10","doi-asserted-by":"publisher","first-page":"e8262","DOI":"10.1097\/MD.0000000000008262","article-title":"Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors","volume":"96","author":"Lin","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.3233\/CBM-201026_ref11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","article-title":"Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma","volume":"56","author":"Leroy","year":"2010","journal-title":"Histopathology"},{"issue":"2","key":"10.3233\/CBM-201026_ref12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10549-016-4057-8","article-title":"Endocan as a prognostic biomarker of triple-negative breast cancer","volume":"161","author":"Sagara","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/CBM-201026_ref13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jso.23317","article-title":"Overexpression of RING box protein 1 (RBX1) associated with poor prognosis of nonmuscle-invasive bladder transitional cell carcinoma","volume":"107","author":"Wang","year":"2013","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.3233\/CBM-201026_ref14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbcan.2005.08.004","article-title":"Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy","volume":"1765","author":"Sarrazin","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.3233\/CBM-201026_ref15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cvr\/cvp332","article-title":"Targeting cancer vasculature via endoglin\/CD105: A novel antibody-based diagnostic and therapeutic strategy in solid tumours","volume":"86","author":"Fonsatti","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.3233\/CBM-201026_ref16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3892\/br.2015.438","article-title":"Endocan: A new marker for cancer and a target for cancer therapy (review)","volume":"3","author":"Yang","year":"2015","journal-title":"Biomed Rep"},{"issue":"51","key":"10.3233\/CBM-201026_ref17","doi-asserted-by":"publisher","first-page":"48341","DOI":"10.1074\/jbc.M108395200","article-title":"Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity","volume":"276","author":"B\u00e9chard","year":"2001","journal-title":"J Biol Chem"},{"issue":"18","key":"10.3233\/CBM-201026_ref18","first-page":"6084","article-title":"Overexpression of endocan induces tumor formation","volume":"63","author":"Scherpereel","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"10.3233\/CBM-201026_ref19","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/or.2012.2012","article-title":"Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1\u03b1 in human colon carcinoma: Impact of ESM-1 on prognosis and its correlation with clinicopathological features","volume":"28","author":"Kim","year":"2012","journal-title":"Oncol Rep"},{"issue":"1","key":"10.3233\/CBM-201026_ref20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00001703-200502000-00010","article-title":"Lobular carcinoma in situ and invasive lobular cancer of the breast","volume":"17","author":"Cocquyt","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"61","key":"10.3233\/CBM-201026_ref21","doi-asserted-by":"publisher","first-page":"103047","DOI":"10.18632\/oncotarget.21461","article-title":"Treatment and survival outcomes of lobular carcinoma in situ of the breast: A SEER population based study","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-201026_ref22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"Van\u2019t\u00a0Veer","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.3233\/CBM-201026_ref23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/147323001003800213","article-title":"Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion","volume":"38","author":"Chen","year":"2010","journal-title":"J Int Med Res"},{"issue":"15","key":"10.3233\/CBM-201026_ref24","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","article-title":"Endocan expression and relationship with survival in human non-small cell lung cancer","volume":"12","author":"Grigoriu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.3233\/CBM-201026_ref25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.7150\/ijms.21023","article-title":"Overexpression of endothelial cell-specific molecule 1 correlates with gleason score and expression of androgen receptor in prostate carcinoma","volume":"14","author":"Lai","year":"2017","journal-title":"Int J Med Sci"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-201026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:22Z","timestamp":1777385302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-201026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":25,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/cbm-201026","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}